Social partner participation in the management of the COVID‐19 crisis: Tripartite social dialogue in Italy, Portugal and Spain
International Labour Review · 2022-03 · 161 (1) · 149-167
DOI: 10.1111/ilr.12362 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Labour Review, online erschienen am 17.03.2022. Verfasst von Sergio Canalda Criado. Beteiligte Einrichtung: Universitat Pompeu Fabra Barcelona. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This article analyses actual social dialogue experiences in Italy, Portugal and Spain in order to examine the social partners’ participation in COVID‐19 crisis management. It considers the economic and political variables that have helped revitalize tripartism in all three countries relative to the previous economic crisis. The lack of austerity policies and responsibility‐sharing on the part of the social partners and governments paved the way for various agreements that, though differing in content and scope, attest to stronger peak‐level tripartite dialogue.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universitat Pompeu Fabra Barcelona.
Zitieren
APA
Canalda Criado, S. (2022). Social partner participation in the management of the COVID‐19 crisis: Tripartite social dialogue in Italy, Portugal and Spain. International Labour Review, 161(1), 149-167. https://doi.org/10.1111/ilr.12362
Vancouver
Canalda Criado S. Social partner participation in the management of the COVID‐19 crisis: Tripartite social dialogue in Italy, Portugal and Spain. International Labour Review. 2022;161(1):149-167. doi:10.1111/ilr.12362
BibTeX
@article{CanaldaCriado2022,
author = {Canalda Criado, Sergio},
title = {Social partner participation in the management of the COVID‐19 crisis: Tripartite social dialogue in Italy, Portugal and Spain},
journal = {International Labour Review},
year = {2022},
volume = {161},
number = {1},
pages = {149--167},
doi = {10.1111/ilr.12362}
}
EUVIMED